Versor Investments’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,864,835
Closed -$31.2M 932
2022
Q4
$31.2M Buy
1,864,835
+422,988
+29% +$7.15M 2.68% 14
2022
Q3
$24.7M Buy
1,441,847
+1,422,047
+7,182% +$22.3M 1.47% 18
2022
Q2
$155K Sell
19,800
-7,800
-28% -$67K 0.01% 763
2022
Q1
$306K Buy
+27,600
New +$309K 0.01% 483

Versor Investments's ONEM Position: Q1 2023 in Review

Versor Investments sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 1,864,835 shares — an estimated $31.2M sold.

Versor Investments first reported a position in ONEM in Q1 2022 and held it in 4 quarters. The position peaked at $31.2M in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Versor Investments reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Versor Investments sold 1,864,835 1Life Healthcare shares in Q1 2023, an estimated $31.2M.
  • Versor Investments first reported a position in 1Life Healthcare in Q1 2022 and held it in 4 quarters.
  • Versor Investments's 1Life Healthcare position peaked at $31.2M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Versor Investments's 13F filing for Q1 2023, filed 5 May 2023.